Vikram Karnani

SVP, Rheumatology Bus. Unit, Horizon Therapeutics Public Ltd Co.

Companies

Dyne Therapeutics, Inc.Board member Dec 23, 2025 to now¹
COLLEGIUM PHARMACEUTICAL, INCBoard member Nov 14, 2024 to now²
COLLEGIUM PHARMACEUTICAL, INCChief executive officer Nov 14, 2024 to now²
COLLEGIUM PHARMACEUTICAL, INCPresident Nov 14, 2024 to now²
Horizon Therapeutics Public Ltd CoSVP, Rheumatology Bus. Unit Mar 3, 2017 to Feb 23, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

COLLEGIUM PHARMACEUTICAL, INC COLL197,864 shares⁴$4.6M at $23.19Feb 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 10, 2026Shares withheld for tax 11,296 shares at $46.75 of COLLEGIUM PHARMACEUTICAL, INC⁴
Feb 10, 2026Granted 32,531 shares of COLLEGIUM PHARMACEUTICAL, INC⁴
Feb 10, 2026Granted 79,264 shares of COLLEGIUM PHARMACEUTICAL, INC⁴
Nov 12, 2025Shares withheld for tax 8,983 shares at $47.35 of COLLEGIUM PHARMACEUTICAL, INC⁵
Nov 12, 2024Granted 105,972 shares of COLLEGIUM PHARMACEUTICAL, INC⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDyne Therapeutics, Inc., Board member
2
SEC EDGARCOLLEGIUM PHARMACEUTICAL, INC, Board member
3
SEC EDGARHorizon Therapeutics Public Ltd Co, SVP, Rheumatology Bus. Unit
4
SEC EDGARCOLLEGIUM PHARMACEUTICAL, INC shares after the filing of Feb 10, 2026
5
SEC EDGARForm 4 filed Nov 14, 2025
6
SEC EDGARForm 4 filed Nov 14, 2024